StockData
Protagenic Therapeutics, Inc.new logo

Protagenic Therapeutics, Inc.new (PTIX) stock

PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.36MP/E –Yield –

Protagenic Therapeutics, Inc.new price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Protagenic Therapeutics, Inc.new's price to book ratio was 0.8× on Oct 19, 2026, against 1.5× a year earlier. Over the last 3 years it ranged from 0.6× to 3.2×, with a median of 1.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.8×−0.9
2024Apr 30, 20241.7×+0.6
2023Dec 29, 20231.0×+0.1
2022Dec 30, 20220.9×−1.9
2021Oct 29, 20212.8×–

More Protagenic Therapeutics, Inc.new figures

See a number that looks wrong?